Inmode Ltd
Slēgts
SektorsVeselības aprūpe
13.5 -0.37
Pārskats
Akcijas cenas izmaiņa
24h
Min
13.39
Max
13.57
Ienākumi | -15M 12M |
|---|---|
Pārdošana | -22M 82M |
P/E Sektora vidējais | 10.052 49.052 |
EPS | 0.25 |
Peļņas marža | 14.097 |
Darbinieki | 660 |
EBITDA | -17M 15M |
Rekomendācijas | Neitrāls |
|---|---|
Prognoze 12 mēnešiem | +16.06% upside |
Nākamie ieņēmumi | 2026. g. 29. jūl. |
|---|
Tirgus kapitalizācija | -81M 825M |
|---|---|
Iepriekšējā atvēršanas cena | 13.87 |
Iepriekšējā slēgšanas cena | 13.5 |
Ziņu noskaņojums
By Acuity
50%
50%
162 / 342 Rangs Healthcare
Inmode Ltd Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Inmode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.